After hours: September 26 at 7:19 PM EDT ...

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of ...

DNA methylation is one of the mechanisms hypothesised in the DOHaD model.20 Comprehensive epigenetic analysis will be performed to investigate DNA methylation in the umbilical cord,21 using a ...

BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...

The call was made by the founder of Chair Centre Group, Ibukun Awosika, at the ISCAN’s 48th Annual Conference, held on Thursday in Lagos. She stated that the conference’s theme: “Reassessing ...

Though Illumina said goodbye to Grail this past summer—after butting heads for years with antitrust regulators and activist investors, while enduring heavy fines and orders to split—the ...

Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that sometimes cause impaired decision-making and poor ... New Therapy That Targets and ...

A top court in the EU on Tuesday ruled against the European Commission's decision to review Illumina's (NASDAQ:ILMN) 2021 acquisition of cancer test developer Grail (NASDAQ:GRAL), eliminating the ...

Gene sequencing company Illumina took a legal gamble in the summer of 2021, closing on its purchase of Grail, a former business unit it spun off in 2016, before European competition regulators had ...

从芯片扫描转换至测序 在一台研究设备上进行新一代测序（NGS）和细胞遗传学芯片扫描。NextSeq 550Dx系统结合了高质量的芯片扫描和广泛采用的Illumina测序技术。利用NextSeq 550Dx系统上的芯片扫描，研究人员能够立即使用到这种强大的互补技术，验证通过测序检测 ...